Search

Learn about asbestos exposure and other serious risk factors for developing mesothelioma.

… Asbestos Exposure The main risk factor for developing mesothelioma is being exposed to asbestos. Asbestos is a fibrous substance that was widely used as a building material from the 1950s to the 1990s in the United States. It was valued for its insulating and fire-resistant properties, among others.

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease. It is characterized by the destruction of red blood cells.

… Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease in which red blood cells break apart. The Ham test and flow cytometry are two blood tests used to diagnose PNH. What Is the Ham Test? The Ham test checks whether red blood cells become more fragile when they are placed in mild acid. What

Learn about active Kaposi sarcoma clinical trials happening now at Memorial Sloan Kettering, where you may have access to treatments before they’re available elsewhere.

… Our physicians and researchers continue to investigate new ways to treat Kaposi sarcoma. As a patient at Memorial Sloan Kettering, you may have access to novel therapies for the disease that are not available elsewhere through one of our clinical trials. Our investigators also participate in national

Memorial Sloan Kettering experts can help you understand your risk for developing ovarian, peritoneal, or fallopian tube cancer.

… There is no way to guarantee that you won’t develop cancer in your ovaries, peritoneum (a layer of tissue that lines your abdomen), or fallopian tubes. Most women have an approximately 1 in 70 chance of being diagnosed with one of these three cancers at some point in their lives. Aging is one risk factor

Learn how often you need to come back for care if you have completed treatment for soft tissue sarcoma.

… Once you have completed treatment for soft tissue sarcoma, your doctors will want you to come back for regular appointments so we can monitor you for side effects of treatment and signs that the cancer has returned. These checkups may include a physical exam, X-rays or other imaging tests, and biopsies

Find out what’s involved in active surveillance for prostate cancer and why some men choose this option.

… Not all prostate cancers are the same. Some grow quickly and need treatment right away. Others grow slowly and are less likely to metastasize (spread) to other parts of your body. This kind of prostate cancer is low risk. If you have a prostate cancer that grows slowly, your healthcare provider may recommend

Descubra en qué consiste la observación activa del cáncer de próstata y por qué algunos hombres eligen esta opción.

… No todos los casos de cáncer de próstata son iguales. Algunos crecen rápidamente y necesitan tratamiento de inmediato. Otros crecen con lentitud y es menos probable que hagan metástasis (se diseminen) a otras partes del cuerpo. Este tipo de cáncer de próstata es de bajo riesgo. Si usted tiene un tipo

We’re here to help you handle any side effects that may develop after your treatment for prostate cancer and to monitor your health carefully over time.

… At Memorial Sloan Kettering, we know that even though you may have finished your cancer treatments, there are still many ways we can help you live a full life —from addressing any side affects you may have to monitoring your health carefully over time. In addition to watching for signs that your cancer

Explore our continually updated listing of clinical trials for cervical cancer.

… Clinical trials at Memorial Sloan Kettering may give you access to new therapies that aren’t widely available. These research studies evaluate the safety and effectiveness of new ways to diagnose and treat cervical cancer. They can also give your treatment team information about your current plan of

Acute lymphocytic leukemia (ALL) is a rare cancer in adults, but it is the most common form of leukemia in children. Read more about what doctors at MSK are looking for when they diagnose ALL.

… Acute lymphocytic leukemia (ALL) is a rare cancer. It affects about 3,000 adults in the United States each year. The incidence of the disease increases with age. It is less common among women and African Americans. Could CAR T-Cell Therapy Be a Cure for Some Cancers? Discover the revolutionary potential